Blue Shield Rx Enhanced 2026 Medicare Part D Plan Available in California
Blue Shield Rx Enhanced is a Medicare Part D prescription drug plan offered by Blue Shield of California for the 2026 plan year. This plan is available to residents of California and provides outpatient prescription drug coverage, with costs based on premiums, a deductible, and tiered cost-sharing for medications.
Updated: .
| Blue Shield Rx Enhanced: Part D Plan Overview | |
|---|---|
| Part D Plan ID: | S2468-004 |
| Plan Year: | 2026 |
| Total Part D Premium: | $227.80 |
| Annual Deductible: | $0.00 |
| Part D Benefit Type: | Enhanced |
| No Deductible Drug Tier: | Not Applicable |
| Low Income Subsidy: | Yes |
| Insured By: | Blue Shield of California |
Prescription Drug Costs
In addition to the monthly premium, Blue Shield Rx Enhanced may include a deductible and tier-based cost-sharing for medications. The sections below outline how prescription drug costs are applied under this plan.
Monthly Premium
Blue Shield Rx Enhanced has a monthly premium that contributes to the total cost of coverage. The table below shows the premium amount for the 2026 plan year.
| Basic Part D Premium: | $185.50 |
| Supplemental Part D Premium: | $42.30 |
| Total Part D Premium: | $227.80 |
| Low Income Premium Subsidy: | $12.00 |
| Low Income Premium Subsidy CMS Pays: | $12.00 |
| Low Income Subsidy Premium: | $215.80 |
The Low-Income Subsidy (LIS), also known as “Extra Help,” provides financial assistance with Medicare Part D costs for qualifying individuals. See the SSA Extra Help page for details.
Annual Deductible
The 2026 Medicare Part D deductible for Blue Shield Rx Enhanced is $0.00. You pay this amount before Blue Shield of California begins covering prescription drug costs.
Prescription Drug Cost Sharing
Blue Shield Rx Enhanced uses tier-based copayments or coinsurance for covered drugs. Costs apply after any deductible and vary by medication tier. See the table below for details.
| Drug Tier | Retail | Mail Order | |
|---|---|---|---|
| Preferred Generic | $2.00 | $0.00 | |
| Generic | $7.00 | $0.00 | |
| Preferred Brand | $43.00 | $0.00 | |
| Non-Preferred Drug | 47.00% | 0.00% | |
| Specialty Tier | 33.00% | 33.00% | |
| *Deductible does not apply. | |||
CMS Star Ratings
Medicare Part D plans are rated from 1 to 5 stars by CMS, based on quality and performance. Higher ratings indicate stronger overall results. The table below displays the rating for Blue Shield Rx Enhanced.
| CMS Measure | Star Rating |
|---|---|
| Overall Plan Rating | |
| Drug Plan Customer Service | |
| Complaints and Changes in the Drug Plan | |
| Member Experience with the Drug Plan | |
| Drug Safety and Accuracy of Drug Pricing |
Contact Information for Blue Shield of California
| Website: | Blue Shield of California Plan Page |
|---|---|
| Formulary: | Blue Shield of California Formulary Page |
| Pharmacy: | Blue Shield of California Pharmacy Page |
| Prospective Part D Members: | (888)292-7591 |
| Prospective Part D TTY Users: | 711 |
- CMS.gov, Landscape Source Files — Last accessed May 2, 2026
- CMS.gov, Medicare Part C & D Performance — Last accessed May 2, 2026
- CMS.gov, Plan Benefits Package — Last accessed May 2, 2026
- CMS.gov, Monthly Enrollment by Contract/Plan/State/County — Last accessed May 2, 2026
Data sources and methodology documentation..
- Blue Shield of California (official source), http://blueshieldca.com/medicare — Last accessed April 27, 2026
- Medicare.gov, "How to get prescription drug coverage" — Last accessed May 2, 2026
- Medicare.gov, "What Medicare Part D drug plans cover" — Last accessed May 1, 2026
- Medicare.gov, "Costs for Medicare drug coverage" — Last accessed May 1, 2026
MedicarePlans.com is an independent, non-government informational resource and is not affiliated with or endorsed by the U.S. Government or the federal Medicare program.
Data provenance is documented in accordance with the U.S. Core Data for Interoperability (USCDI) Provenance standard.
Page content independently curated and maintained by David W. Bynon, Editorial Steward, using a standardized, data-driven methodology for accurate, non-commercial Medicare plan interpretation and resolution.